|
1
|
Ura B, Monasta L, Arrigoni G, Licastro D,
Di Lorenzo G, Romano F, Gaita B, Scrimin F and Ricci G: Leiomyoma
phosphoproteins involved in inhibition of oxidative stress and
synthesis of reactive oxygen species. Int J Mol Med. 44:2329–2335.
2019.PubMed/NCBI
|
|
2
|
Kim JJ and Sefton EC: The role of
progesterone signaling in the pathogenesis of uterine leiomyoma.
Mol Cell Endocrinol. 358:223–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haney AF: Clinical decision making
regarding leiomyomata: What we need in the next millenium. Environ
Health Perspect. 108 (Suppl 5):S835–S839. 2000. View Article : Google Scholar
|
|
4
|
Ura B, Di Lorenzo G, Romano F, Monasta L,
Mirenda G, Scrimin F and Ricci G: Interstitial fluid in gynecologic
tumors and its possible application in the clinical practice. Int J
Mol Sci. 19:40182018. View Article : Google Scholar
|
|
5
|
Ura B, Monasta L, Arrigoni G, Battisti I,
Licastro D, Di Lorenzo G, Romano F, Aloisio M, Peterlunger I,
Stabile G, et al: Phosphoproteins involved in the inhibition of
apoptosis and in cell survival in the leiomyoma. J Clin Med.
8:6912019. View Article : Google Scholar
|
|
6
|
Ura B, Scrimin F, Arrigoni G, Aloisio M,
Monasta L and Ricci G: Dysregulated chaperones associated with cell
proliferation and negative apoptosis regulation in the uterine
leiomyoma. Oncol Lett. 15:8005–8010. 2018.PubMed/NCBI
|
|
7
|
Ura B, Scrimin F, Zanconati F, Arrigoni G,
Monasta L, Romano A, Banco R, Zweyer M, Milani D and Ricci G:
Two-dimensional gel electrophoresis analysis of the leiomyoma
interstitial fluid reveals altered protein expression with a
possible involvement in pathogenesis. Oncol Rep. 33:2219–2226.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kashani BN, Centini G, Morelli SS, Weiss G
and Petraglia F: Role of medical management for uterine leiomyomas.
Best Pract Res Clin Obstet Gynaecol. 34:85–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shin SJ, Kim J, Lee S, Baek J, Lee JE, Cho
C and Ha E: Ulipristal acetate induces cell cycle delay and
remodeling of extracellular matrix. Int J Mol Med. 42:1857–1864.
2018.PubMed/NCBI
|
|
10
|
Sohn GS, Cho S, Kim YM, Cho CH, Kim MR and
Lee SR; Working Group of Society of Uterine Leiomyoma, : Current
medical treatment of uterine fibroids. Obstet Gynecol Sci.
61:192–201. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bendifallah S, Brun JL and Fernandez H:
Myomectomy for infertile women: The role of surgery. J Gynecol
Obstet Biol Reprod (Paris). 40:885–901. 2011.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yun BS, Seong SJ, Cha DH, Kim JY, Kim ML,
Shim JY and Park JE: Changes in proliferating and apoptotic markers
of leiomyoma following treatment with a selective progesterone
receptor modulator or gonadotropin-releasing hormone agonist. Eur J
Obstet Gynecol Reprod Biol. 191:62–67. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Horak P, Mara M, Dundr P, Kubinova K,
Kuzel D, Hudecek R and Chmel R: Effect of a selective progesterone
receptor modulator on induction of apoptosis in uterine fibroids in
vivo. Int J Endocrinol. 2012:4361742012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maruo T, Ohara N, Yoshida S, Nakabayashi
K, Sasaki H, Xu Q, Chen W and Yamada H: Translational research with
progesterone receptor modulator motivated by the use of
levonorgestrel-releasing intrauterine system. Contraception.
82:435–441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ura B, Monasta L, Arrigoni G, Franchin C,
Radillo O, Peterlunger I, Ricci G and Scrimin F: A proteomic
approach for the identification of biomarkers in endometrial cancer
uterine aspirate. Oncotarget. 8:109536–109545. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ura B, Scrimin F, Arrigoni G, Franchin C,
Monasta L and Ricci G: A proteomic approach for the identification
of up-regulated proteins involved in the metabolic process of the
leiomyoma. Int J Mol Sci. 17:5402016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eaton SL, Roche SL, Llavero Hurtado M,
Oldknow KJ, Farquharson C, Gillingwater TH and Wishart TM: Total
protein analysis as a reliable loading control for quantitative
fluorescent Western blotting. PLoS One. 8:e724572013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Welinder C and Ekblad L: Coomassie
staining as loading control in western blot analysis. J Proteome
Res. 10:1416–1419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Small B, Millard CEF, Kisanga EP, Burman
A, Anam A, Flannery C, Al-Hendy A and Whirledge S: The selective
progesterone receptor modulator ulipristal acetate inhibits the
activity of the glucocorticoid receptor. J Clin Endocrinol Metab.
105:716–734. 2020. View Article : Google Scholar
|
|
20
|
Sabry M and Al-Hendy A: Medical treatment
of uterine leiomyoma. Reprod Sci. 19:339–353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen JW, Dodia C, Feinstein SI, Jain MK
and Fisher AB: 1-Cys peroxiredoxin, a bifunctional enzyme with
glutathione peroxidase and phospholipase A2 activities. J Biol
Chem. 275:28421–28427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kang SW, Baines IC and Rhee SG:
Characterization of a mammalian peroxiredoxin that contains one
conserved cysteine. J Biol Chem. 273:6303–6311. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pizzino G, Irrera N, Cucinotta M, Pallio
G, Mannino F, Arcoraci V, Squadrito F, Altavilla D and Bitto A:
Oxidative stress: Harms and benefits for human health. Oxid Med
Cell Longev. 2017:84167632017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nocella C, Cammisotto V, Pigozzi F,
Borrione P, Fossati C, D'Amico A, Cangemi R, Peruzzi M, Gobbi G,
Ettorre E, et al: Impairment between oxidant and antioxidant
systems: Short- and long-term implications for athletes' health.
Nutrients. 11:13532019. View Article : Google Scholar
|
|
25
|
Akerlöf E, Jörnvall H, Slotte H and
Pousette A: Identification of apolipoprotein A1 and immunoglobulin
as components of a serum complex that mediates activation of human
sperm motility. Biochemistry. 30:8986–8990. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mao J, Liu W and Wang Y: Apolipoprotein
A-I expression suppresses COX-2 expression by reducing reactive
oxygen species in hepatocytes. Biochem Biophys Res Commun.
454:359–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsai MH, Lin ZC, Liang CJ, Yen FL, Chiang
YC and Lee CW: Eupafolin inhibits PGE2 production and COX2
expression in LPS-stimulated human dermal fibroblasts by blocking
JNK/AP-1 and Nox2/p47(phox) pathway. Toxicol Appl Pharmacol.
279:240–251. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun X, Ou Z, Xie M, Kang R, Fan Y, Niu X,
Wang H, Cao L and Tang D: HSPB1 as a novel regulator of ferroptotic
cancer cell death. Oncogene. 34:5617–5625. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rogalla T, Ehrnsperger M, Preville X,
Kotlyarov A, Lutsch G, Ducasse C, Paul C, Wieske M, Arrigo AP,
Buchner J and Gaestel M: Regulation of Hsp27 oligomerization,
chaperone function, and protective activity against oxidative
stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem.
274:18947–18956. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Collier MP, Alderson TR, de Villiers CP,
Nicholls D, Gastall HY, Allison TM, Degiacomi MT, Jiang H, Mlynek
G, Fürst DO, et al: HspB1 phosphorylation regulates its
intramolecular dynamics and mechanosensitive molecular chaperone
interaction with filamin C. Sci Adv. 5:eaav84212019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Razinia Z, Mäkelä T, Ylänne J and
Calderwood DA: Filamins in mechanosensing and signaling. Annu Rev
Biophys. 41:227–246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang L, Hong Q, Xu SG, Kuang XY, Di GH,
Liu GY, Wu J, Shao ZM and Yu SJ: Downregulation of transgelin 2
promotes breast cancer metastasis by activating the reactive oxygen
species/nuclear factor-κB signaling pathway. Mol Med Rep.
20:4045–4258. 2019.PubMed/NCBI
|
|
33
|
Shapland C, Hsuan JJ, Totty NF and Lawson
D: Purification and properties of transgelin: A transformation and
shape change sensitive actin-gelling protein. J Cell Biol.
121:1065–1073. 1993. View Article : Google Scholar : PubMed/NCBI
|
